AD, JAK Inhibitors, Psoriasis Among Topics Highlighted at 2023 Fall Clinical Dermatology Conference
October 16th 2023The 2023 Fall Clinical Dermatology conference will take place in Las Vegas and be livestreamed from October 19 to 22; topics of interest to be covered include atopic dermatitis (AD), Janus kinase (JAK) inhibitors, and psoriasis.
Read More
Perioperative Pembrolizumab Meets Dual Primary End Point of OS in NSCLC
October 14th 2023Pembrolizumab plus chemotherapy prior to surgery, followed by resection and single-agent pembrolizumab in the adjuvant setting, significantly improved overall survival (OS) vs neoadjuvant placebo plus chemotherapy followed by adjuvant placebo in patients with resectable stage II, IIIA, or IIIB (T3-4N2) non–small cell lung cancer, meeting the dual primary end point of the phase 3 KEYNOTE-671 trial.
Read More
Unstructured Physical Activity Lowers Glucose, but Increases Risk of Hypoglycemia in T1D
October 14th 2023Results show engaging in unstructured physical activities, even those of low intensity and carried out in the morning and early afternoon, is linked to reduced average glucose levels throughout the day and night.
Read More
Calprotectin, Microbiota Levels Can Predict C difficile Recurrence, Study Finds
October 14th 2023Age, fecal calprotectin level, toxin B polymerase chain reaction cycle threshold, immunosuppression, sex, and creatinine levels were identified as independent risk factors for developing recurrent Clostridioides difficile infection.
Read More
Oncology Financial Navigator Ensures Vital Care Access, Eases Economic Burden
October 13th 2023According to the National Cancer Institute, in the year following a cancer diagnosis, the average cost of medical care plus medication exceeds $42,000, with some treatments having a price tag of more than $1 million.
Read More
ASRM 2023: Integrating Advances and Addressing Challenges in Reproductive Medicine
October 13th 2023The American Society of Reproductive Medicine (ASRM) 2023 Scientific Congress & Expo in New Orleans will focus on the latest advancements and challenges in reproductive health, including new treatments and technology, evolving legislation, and the importance of professional guidelines.
Read More
Medicare Part A and B premiums are set to increase by $9.80 next year; 20 experts from various specialties and institutions have developed updated brain death guidelines; many Black patients are strongly affected by multiple COVID-19 infections due to a lack of health insurance and health care access.
Read More
Gefapixant Made Modest Symptom Improvements in Patients With Chronic Cough, Review Says
October 12th 2023Based on the researchers’ findings, gefapixant provides small benefits in cough severity, cough frequency, and cough-specific quality of life in patients with refractory or unexplained chronic coughs.
Read More
COVID-19, Flu, and RSV Vaccine Skepticism Still an Issue Among Many Americans
October 12th 2023During a podcast hosted by Permanente Medicine, Sandra Fryhofer, MD, chair-elect of the Board of Trustees for the American Medical Association and a liaison to the CDC’s Advisory Committee on Immunization Practices, discussed the importance of vaccines for the fall and winter seasons.
Read More
What We’re Reading: Alzheimer Blood Tests; Year-Long Adderall Shortage; Type 2 Diabetes Management
October 12th 2023Blood tests offer a less invasive and more accessible means of detecting Alzheimer disease; Democrats address a year-long Adderall shortage; A new study shows significantly improved clinical outcomes in Type 2 diabetes management with a digital behavioral therapy app.
Read More
Evaluating WHO's Hemophilia Treatment Choices: Patient Safety, Access Challenges
October 12th 2023A commentary questions the characterization of cryoprecipitate, which is not pathogen-reduced, as an alternative modality for treating hemophilia, despite its substantial risk of transmitting blood-borne pathogens to patients.
Read More